Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX4YGF
|
||||
Drug Name |
2-(4-chloro-6-(2,3-dihydro-1H-inden-5-ylamino)pyrimidin-2-ylthio)-2-(naphthalen-1-yl)acetic acid
|
||||
Synonyms |
CHEMBL1089158
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H20ClN3O2S
|
||||
Canonical SMILES |
OC(=O)C(Sc1nc(Cl)cc(Nc2ccc3CCCc3c2)n1)c4cccc5ccccc45
|
||||
InChI |
InChI=1S/C25H20ClN3O2S/c26-21-14-22(27-18-12-11-15-6-3-8-17(15)13-18)29-25(28-21)32-23(24(30)31)20-10-4-7-16-5-1-2-9-19(16)20/h1-2,4-5,7,9-14,23H,3,6,8H2,(H,30,31)(H,27,28,29)
|
||||
InChIKey |
VNPBXBNWSYMQTB-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | [1587926] | ||
Arachidonate 5-lipoxygenase | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear ReceptorsWP2877:Vitamin D Receptor Pathway | |||||
Arachidonic acid metabolism | |||||
Eicosanoid Synthesis | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.